Carbon emission reduction associated with dapagliflozin compared to standard of care in the UK: translating the DAPA-HF and DELIVER trial findings to an environmental context
AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)
0
follower
7
more
presentations
in this session
Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine according to time of day of vaccination: a post-hoc analysis of the DANFLU-1 randomised clinical trial